Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 10:15PM GMT
Release Date Price: $125.51 (-1.64%)
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Jess Fye. I'm a Senior Biotech Analyst at JPMorgan, and we're continuing the 42nd Annual Healthcare Conference today with Jazz. I'm joined by the company's Chairman and CEO, Bruce Cozadd, who's going to give a presentation. And then we're going to move into Q&A with a couple of other members of management team on stage.

If you are in the room and you want to ask a question, you can raise your hand and someone will bring you a mic or you can always use the portal to send me questions on the iPad up here. So with that, let me turn it over to Bruce.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Thank you, Jess, and thank you all for being here. So the 42nd Annual JPMorgan Healthcare Conference, I've only been at the last 33, so I missed a couple, the last 20 representing Jazz Pharmaceuticals. And I have to say, I'm delighted to be here to give you an update on the accomplishments of the company in 2023, but more

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot